Defense Department to Buy Up to $6.6M in Medicine From Cadence Pharmaceuticals

The U.S. Department of Defense said it will buy up to $6.6 million worth of acetaminophen injections from San Diego-based Cadence Pharmaceuticals Inc.

The Defense Logistics Agency Troop Support office in Philadelphia is the contracting office, exercising the first option year of a contract that could last as long as eight years. The deal is an indefinite delivery, indefinite quantity, firm fixed price contract.

The Army, Air Force and Marine Corps will use the medicine.

Cadence Pharmaceuticals (Nasdaq: CADX) is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.